Zenith Drugs Limited IPO

Zenith Drugs Limited IPO

  • IPO Date19 Feb, 2024 to 22 Feb, 2024
  • Listing Date27 Feb, 2024
  • Face Value₹10 per share
  • Issue Price₹75 to ₹79 per share
  • Lot Size1600 Shares
  • Minimum Investment₹1,26,400
  • Listing AtNSE SME
  • Total Issue Size51,48,800 Shares
    (aggregating up to ₹40.68 Cr)
  • Fresh Issue51,48,800 Shares
    (aggregating up to ₹40.68 Cr)
  • Offer for Sale-
  • Issue TypeBook Built Issue IPO
  • Share holding pre issue1,20,00,000
  • Shareholding post issue1,71,48,800
IPO Dates

Closing Date

22 Feb, 2024

Initiation of Refunds

26 Feb, 2024

Listing Date

27 Feb, 2024

19 Feb, 2024

Opening Date

23 Feb, 2024

Basis of Allotment

26 Feb, 2024

Credit of Shares

UPI Mandate Expiry Date:22 Feb, 2024

Zenith Drugs Limited Lot Size

Investors can bid for a minimum of 1600 shares and in multiples thereof. The below table depicts the minimum and maximum investment by retail investors and HNI in terms of shares and amount.

ApplicationLotsSharesAmount
Retail (Min)11600₹1,26,400
HNI (Min)23200₹2,52,800
Retail (Max)11600₹1,26,400

Zenith Drugs Limited Promoter Holding

The promoters of the company are Mr. Sandeep Bhardwaj, Mr. Bhupesh Soni and Mr. Ajay Singh Dassundi

Pre Issue Share HoldingPost Issue Share Holding
100%69.98%

Zenith Drugs Limited COMPANY INFORMATION

Zenith Drugs IPO is a book built issue of Rs 40.68 crores. The issue is entirely a fresh issue of 51.49 lakh shares. Zenith Drugs IPO bidding started from February 19, 2024 and ended on February 22, 2024. The allotment for Zenith Drugs IPO was finalized on Friday, February 23, 2024. Zenith Drugs IPO will list on NSE SME with tentative listing date fixed as Tuesday, February 27, 2024. Zenith Drugs IPO price band is set at ₹75 to ₹79 per share. The minimum lot size for an application is 1600 Shares. The minimum amount of investment required by retail investors is ₹126,400. The minimum lot size investment for HNI is 2 lots (3,200 shares) amounting to ₹252,800. Gretex Corporate Services Limited is the book running lead manager of the Zenith Drugs IPO, while Bigshare Services Pvt Ltd is the registrar for the issue. The market maker for Zenith Drugs IPO is Gretex Share Broking. Refer to Zenith Drugs IPO RHP for detailed information.

Incorporated in 2000, Zenith Drugs Limited is a pharmaceutical company specialising in manufacturing and trading high-quality, affordable medicines, including generic drugs.

The company adheres to WHO-GMP guidelines and has received the ISO 9001:2015 certification from a respected EuroUK certification body, demonstrating its commitment to quality.

The product portfolio of the company includes 

  • ORS Powder;
  • Liquid Orals;
  • Ointments;
  • Liquid Externals; and
  • Capsules

The Food & Drugs Administration has approved over 600 products, of which 325 are currently in production.

The company is in the process of setting up a new manufacturing facility in Village Muradpura, Depalpur, Indore, Madhya Pradesh.

The company supplies its products to countries such as Costa Rica in Central America and the Caribbean and Pacific regions, Malawi, Mauritius, Mozambique, Sudan, Tanzania, Bhutan , Cambodia in Southeast Asia, Tajikistan, Liberia, Sierra Leone, and Conakry.

Zenith Drugs Limited specializes in third-party manufacturing, also known as white label manufacturing, for esteemed pharmaceutical companies such as Ajanta Pharma, Bio Medical Laboratories, and Zest Pharma, among others.

There are currently 89 employees as of March 31, 2023 - 61 on payroll and 28 on contract.

FAQs About Zenith Drugs Limited Ipo

Zenith Drugs Limited IPO will open on 19 Feb, 2024 and close on 22 Feb, 2024. Investors must apply within this period to participate.

The Zenith Drugs Limited IPO price band is set between ₹75.00 and ₹79.00 per share. The minimum lot size is 1600, requiring an investment of at least ₹126400.00.

The Zenith Drugs Limited IPO shares are expected to be listed on 27 Feb, 2024, subject to regulatory approvals and final allotment.

You can track your Zenith Drugs Limited IPO application status on the registrar’s website: Link Intime or KFintech using your PAN, application number, or DP ID

The Zenith Drugs Limited IPO will be listed on major stock exchanges such as NSE and BSE, where you can trade shares once they are listed.